Home > Financial Ratios > SMS PHARMACEUTICALS

SMS PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for SMS PHARMACEUTICALS
Please provide your vote to see the results

SMS PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 15.559.8720.6919.9417.75

What is the latest Core EBITDA Margin ratio of SMS PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of SMS PHARMACEUTICALS is 15.55 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202415.55
Mar20239.87
Mar202220.69
Mar202119.94
Mar202017.75

How is Core EBITDA Margin of SMS PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 15.55
57.55
Mar2023 9.87
-52.30
Mar2022 20.69
3.76
Mar2021 19.94
12.34
Mar2020 17.75 -

Other Financial Ratios of SMS PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of SMS PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS ₹2,062.9 Cr -3.9% -7.2% 109.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹429,361.0 Cr -1.4% 1.2% 46.9% Stock Analytics
DIVIS LABORATORIES ₹155,274.0 Cr -1.4% 1.8% 60% Stock Analytics
CIPLA ₹117,144.0 Cr -0.3% -3.3% 19.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,134.0 Cr 0.8% 1.8% 13.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,554.4 Cr -1.7% 1.2% 53.9% Stock Analytics


SMS PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SMS PHARMACEUTICALS

-3.9%

-7.2%

109.4%

SENSEX

-1%

3.9%

16%


You may also like the below Video Courses